# Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

> **NCT03034642** · NA · COMPLETED · sponsor: **VA Ann Arbor Healthcare System** · enrollment: 60 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Pneumonia, Bacterial

## Interventions

- **PROCEDURE:** Bronchoscopy with bilateral bronchoalveolar lavages

## Key facts

- **NCT ID:** NCT03034642
- **Lead sponsor:** VA Ann Arbor Healthcare System
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-01
- **Primary completion:** 2020-03-20
- **Final completion:** 2021-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03034642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03034642, "Modulation of Steroid Immunosuppression by Alveolar Efferocytosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03034642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*